Found 8 results
Name | Type of Offering | Accepted Date |
---|---|---|
EP Life Sciences Ltd.
|
D/A | 2019-06-17 15:19:27 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-19-000426
Exclusions or Exemptions
506b
Accepted Date
2019-06-17 15:19:27
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D/A | 2020-06-08 10:41:28 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-20-000283
Exclusions or Exemptions
506b
Accepted Date
2020-06-08 10:41:28
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D/A | 2021-06-08 12:43:48 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-21-000522
Exclusions or Exemptions
506b
Accepted Date
2021-06-08 12:43:48
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D | 2018-06-28 14:51:56 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-18-000414
Exclusions or Exemptions
506b
Accepted Date
2018-06-28 14:51:56
Type of Offering
D
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D/A | 2022-03-28 12:52:59 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-22-000413
Exclusions or Exemptions
506b
Accepted Date
2022-03-28 12:52:59
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D/A | 2023-03-27 14:47:09 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-23-000478
Exclusions or Exemptions
506b
Accepted Date
2023-03-27 14:47:09
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D/A | 2024-03-26 15:34:45 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-24-000370
Exclusions or Exemptions
506b
Accepted Date
2024-03-26 15:34:45
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
EP Life Sciences Ltd.
|
D/A | 2025-03-21 17:09:06 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001744905
Filed Document
0000899140-25-000445
Exclusions or Exemptions
506b
Accepted Date
2025-03-21 17:09:06
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|